The year psychedelics went mainstream omslagsbild

The year psychedelics went mainstream

The year psychedelics went mainstream

Lyssna kostnadsfritt nu, utan abonnemang

Visa detaljer

Das größte Angebot der Saison | 0,99 € pro Monat für die ersten 3 Monate + 15 € Audible-Guthaben

Danach 6,99 €/Monat. Bedingungen gelten. Monatlich kündbar.
Om den här titeln
Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major research trend that flew under the radar this year: increased public and private funding for trials looking into therapeutic psychedelics.
adbl_web_anon_alc_button_suppression_t1
Inga recensioner ännu